(Q36984156)

17 August 2017

1 reference

title

Management of severe sepsis of abdominal origin (English)

1 reference

17 August 2017

0 references

F M Pieracci

1

1 reference

17 August 2017

P S Barie

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2007

1 reference

Scandinavian Journal of Surgery

17 August 2017

published in

1 reference

17 August 2017

volume

96

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

184-196

1 reference

Efficacy and safety of drotrecogin alfa (activated) for the therapy of surgical patients with severe sepsis

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Principles and limitations of operative management of intraabdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Treatment of severe intra-abdominal sepsis and/or necrotic foci by an 'open-abdomen' approach. Zipper and zipper-mesh techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Source control in the management of severe sepsis and septic shock: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

The international sepsis forum consensus conference on definitions of infection in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Nosocomial infections adversely affect the outcomes of patients with serious intraabdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Clinical review: Healing in gastrointestinal anastomoses, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

The microbiology of postoperative peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Etappenlavage: advanced diffuse peritonitis managed by planned multiple laparotomies utilizing zippers, slide fastener, and Velcro analogue for temporary abdominal closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Acute abdomen in the medical intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

The Surviving Sepsis Campaign: raising awareness to reduce mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Impact of CT in patients with sepsis of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

'Laparostomy': a technique for the management of intractable intra-abdominal sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Nitrogen balance, protein loss, and the open abdomen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Planned reoperations and open management in critical intra-abdominal infections: prospective experience in 52 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Meta-analysis of relaparotomy for secondary peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Re-operation for intra-abdominal sepsis. Indications and results in modern critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Management of severe acute pancreatitis: it's all about timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Early versus late necrosectomy in severe necrotizing pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Source control in the management of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Role of resection and primary anastomosis of the left colon in the presence of peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Serious intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Management of complicated intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Aminoglycosides for intra-abdominal infection: equal to the challenge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Implications of leukocytosis and fever at conclusion of antibiotic therapy for intra-abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Management of secondary peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Intraabdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Are there patients with peritonitis who require empiric therapy for enterococcus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Surgical Infections withEnterococcus: Outcome in Patients Treated with Ertapenem versus Piperacillin-Tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Surgical infection stratification system for intra-abdominal infection. Multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Critical issues in the clinical management of complicated intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

Comparison of Intravenous/Oral Ciprofloxacin Plus Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690709600302

10.1177/145749690709600302

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference